Paul Tudor Jones Emergent Bio Solutions Inc. Transaction History

Tudor Investment Corp Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.82 - $3.16 $3,787 - $6,575	2,081 Added 9.3%	24,464 $58,000
Q3 2023 Nov 15, 2023	BUY	$3.17 - $7.91 $70,954 - $177,049	22,383 New	22,383 $76,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $892,712 - $1.42 Million	-32,557 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $1.19 Million - $1.7 Million	32,557 New	32,557 $1.34 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $1.18 Million - $1.96 Million	-35,580 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $1.54 Million - $2.03 Million	30,787 Added 642.33%	35,580 $1.78 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $232,101 - $329,886	-4,100 Reduced 46.1%	4,793 $302,000
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $668,799 - $970,973	-7,756 Reduced 46.59%	8,893 $826,000
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $1.32 Million - $1.86 Million	16,649 New	16,649 $1.49 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.